Select all the dates you'd like to sign-up for and click "Sign Up"
Impact of Precision Medicine in Moderate-to-Severe Asthma: Opportunities for Managed Care
|
|
Jointly provided by
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.